5 Best Cancer Hospitals in the United States

Cancer remains a significant health concern in the United States, affecting millions of individuals each year. The American Cancer Society estimated that  2,001,140 new cancer cases and 611,720 cancer deaths are projected to occur in the United States in 2024. 

Receiving a cancer diagnosis from medical clinics can be a frightening experience, but worry no more as outstanding progress in researching and treating cancer has taken place over the last decades. Innovative and advanced cancer hospitals have emerged in the United States each year. 

In this blog post, we will look into details about the five best cancer hospitals in the United States celebrated for their exceptional progress in cancer research and treatment. Be sure to read through the end.

Key Takeaways

• MD Anderson Cancer Center in Houston has held the No. 1 national ranking for 11 consecutive years and now treats approximately 187,000 patients annually, the highest volume of any dedicated cancer center in the country.
• Memorial Sloan Kettering ranks No. 2 nationally and No. 1 globally in Newsweek’s 2026 World’s Best Specialized Hospitals, reflecting its dual strength in clinical outcomes and international oncology research reputation.
• Dana-Farber Brigham Cancer Center achieved its 25th consecutive year of top national recognition in 2025–2026, with standout performance in leukemia, lymphoma, myeloma, and multiple surgical oncology categories.
• Massachusetts General Hospital made the largest single-year climb in the 2025–2026 rankings, rising from No. 11 to No. 5, driven by its system-wide “For Every Patient” strategy that measurably reduced inpatient mortality.
• All five hospitals hold National Cancer Institute (NCI) Comprehensive Cancer Center designation — the federal government’s highest recognition for oncology research, training, and patient care integration.

What is a Cancer Hospital?

A cancer hospital is a medical facility that specializes in the diagnosis, treatment, and care of individuals diagnosed with cancer. These hospitals are staffed with specialized medical professionals, equipped with advanced technologies, and offer comprehensive support services to address the specific needs of cancer patients.

Cancer hospitals may vary in size and scope, ranging from large comprehensive cancer centers associated with major academic institutions to smaller, specialized facilities. These hospitals aim to provide specialized care, support, and resources to individuals and families affected by cancer.

However, finding the best cancer hospital is crucial. The quality of medical expertise, advanced technologies, and support services can greatly influence patient outcomes. 

What Makes a Cancer Hospital “Best in Class”?

A best-in-class cancer hospital is a medical institution that combines high-volume, specialized oncology care, active research programs, NCI designation, and measurable superiority in patient outcomes — including lower risk-adjusted mortality, lower complication rates, and higher survival rates relative to national benchmarks.

U.S. News evaluates cancer hospitals across more than a dozen objective metrics: risk-adjusted survival and complication rates, nurse staffing ratios, patient volume for high-complexity procedures, advanced clinical technology, and reputation scores from oncologist surveys. Peer reputation accounts for roughly one-third of each facility’s score, reflecting the clinical community’s direct judgment of where they would send their own patients.

NCI Comprehensive Cancer Center designation — held by all five hospitals on this list — confirms that a facility meets federal standards for integrating cancer research directly into patient care protocols.

Top 5 Best Cancer Hospitals in the US 2024

How Are These Rankings Determined?

The U.S. News & World Report Best Hospitals methodology for cancer combines risk-adjusted patient outcomes (survival, complications, and readmission rates), structural measures (nurse-to-patient ratios, access to advanced technology, and board certification rates), procedure volume, and a reputational survey of oncology specialists nationwide. Facilities must meet a minimum volume threshold to qualify, which automatically filters out general hospitals without meaningful cancer specialty programs.

1. MD Anderson Cancer Center

Ranked No. 1 nationally by U.S. News & World Report for 2025–2026 — its 11th consecutive year at the top.

Source

• Address: 1515 Holcombe Blvd. in Houston, Texas 77030
• Phone Line: 844-758-0580

MD Anderson has ranked No. 1 or No. 2 in every U.S. News cancer hospital survey since the ranking launched in 1990 — a 35-year record unmatched by any other facility. It is one of the three original NCI Comprehensive Cancer Centers designated in the United States and currently treats approximately 187,000 patients per year.

The center’s clinical strength rests on the depth of its specialization. MD Anderson receives “High Performing” ratings from U.S. News across colon cancer, leukemia, lymphoma, myeloma, lung, ovarian, prostate, and uterine cancer surgeries. Its multidisciplinary teams, pairing surgical oncologists, medical oncologists, radiation oncologists, pathologists, and palliative care specialists, collectively evaluate each patient rather than sequentially, thereby compressing time-to-treatment decision and reducing diagnostic error.

MD Anderson leads the NCI’s funding allocations for cancer research, supporting work in immunotherapy, precision oncology, and early-detection biomarker development. Its Moon Shots Program — a portfolio of high-priority research initiatives targeting specific cancer types — has directly accelerated the development of treatment protocols now used at institutions nationwide.

Bottom line for patients and referring clinicians: For rare cancers, complex recurrences, or cases where second-opinion expertise is warranted, MD Anderson’s volume, specialization, and research integration make it the national benchmark.

2. Dana-Farber Cancer Institute

Ranked best nationally for 2025–2026 — its 25th consecutive year of top-tier U.S. News recognition.

Source

• Address: 450 Brookline Ave, Boston, MA 02215, United States
• Phone: +1 617-632-3000

Dana-Farber Brigham Cancer Center represents the unified oncology program of two institutions: Dana-Farber Cancer Institute, founded in 1947 as a pediatric cancer research center, and Brigham and Women’s Hospital, one of Harvard Medical School’s primary teaching affiliates. The partnership consolidates research, surgical capability, and inpatient oncology care under a single clinical framework.

U.S. News awards the center “High Performing” ratings in leukemia, lymphoma, myeloma, and surgeries for colon, gynecologic, lung, and prostate cancers. Low mortality rates and strong nursing care scores underpin these category rankings. The center’s 25-year streak of national recognition confirms structural consistency — not a single-year performance anomaly.

Dana-Farber’s research infrastructure has contributed foundational advances in targeted therapy and genomic oncology, and its affiliation with Harvard and the Broad Institute creates an unusually close pathway from laboratory discovery to clinical protocol adoption.

Bottom line for patients and referring clinicians: Dana-Farber Brigham is New England’s premier cancer destination, with particular strength in blood cancers and research-driven treatment protocols that reach patients earlier than at most institutions.

3. Mayo Clinic

Ranked best nationally for 2025–2026, with consistent high-performance scores across multiple cancer categories.

Source

• Address: 200 1st St. SW Rochester, MN 55905
• Phone Line: 507-284-2511

Mayo Clinic’s Rochester campus anchors a three-site cancer system that includes Phoenix, Arizona, and Jacksonville, Florida, providing geographic reach uncommon among top-ranked cancer centers. The Rochester campus drives the national ranking, with category-level strength in radiation oncology, complex surgical oncology, and integrated hematology/oncology programs.

Mayo’s model centers on multispecialty coordination. A patient presenting with a complex diagnosis receives simultaneous evaluation from oncologists, surgeons, radiation specialists, radiologists, and pathologists — not sequential referrals across weeks. This integrated structure compresses diagnostic timelines and is a structural reason for Mayo’s low complication rates in high-complexity procedures.

Mayo participates in the Alliance for Clinical Trials in Oncology, connecting its patients to international research protocols. This trial-network access means patients at Mayo have pathways to experimental therapies comparable to those available at urban research centers, despite Rochester’s geographic location.

Bottom line for patients and referring clinicians: Mayo’s integrated care model and geographic accessibility make it the strongest option in the upper Midwest, and its multispecialty coordination is a distinct structural advantage for diagnostically complex cases.

4. Memorial Sloan Kettering Cancer Center (MSK)

Ranked best nationally (U.S. News 2025–2026) and No. 1 globally (Newsweek 2026 World’s Best Specialized Hospitals).

Source

• Address: 1275 York Ave, New York, NY 10065, United States
• Phone Line: +1 347-798-9213

MSK has treated cancer patients exclusively since 1884 — longer than any other institution on this list. That singular focus underpins a clinical infrastructure built entirely around oncology: every department, every protocol, and every support service exists to optimize cancer outcomes.

MSK became one of the first hospitals to receive the NCI Comprehensive Cancer Center designation in 1971 and has maintained it continuously. Its research division, the Sloan Kettering Institute, directly drove the development of checkpoint inhibitor therapies — including Ipilimumab — and has been central to the clinical advancement of CAR T-cell therapies, now a standard approach in relapsed blood cancers.

MSK’s physician reputation scores are among the highest in any U.S. News specialty ranking, reflecting consistent peer recognition across hematologic malignancies, solid tumors, and surgical oncology. Its clinical trial enrollment rate is one of the highest nationally, meaning a meaningful percentage of MSK patients have access to treatments unavailable elsewhere.

Bottom line for patients and referring clinicians: MSK’s combination of global reputation, immunotherapy leadership, and trial access positions it as the premier option for patients in the Northeast and for those seeking cutting-edge treatment for hematologic cancers.

5. Massachusetts General Hospital

Ranked best nationally for 2025–2026 — the largest single-year rise in the rankings, jumping from No. 11.

Source

• Address: 55 Fruit St, Boston, MA 02114
• Phone: 617-726-2000

Massachusetts General Hospital’s nine-place climb validates a deliberate institutional strategy. The Mass General Brigham system’s “For Every Patient” initiative — a coordinated effort to reduce inpatient mortality through standardized care protocols, team communication improvements, and earlier clinical intervention — produced measurable outcome improvements that U.S. News scoring directly captured.

Mass General Cancer Center houses more than 500 cancer specialists and emphasizes direct translation of research findings into treatment protocols. Strengths include clinical trials enrollment, complex surgical oncology, and access to Harvard Medical School’s research infrastructure.

The center’s rise reflects a broader pattern in the 2025–2026 rankings: institutions that invested systematically in care coordination and team communication demonstrated outcome improvements that translated directly into ranking gains. For healthcare administrators, Mass General’s trajectory reinforces the operational link between clinical communication infrastructure and measurable patient outcomes.

Bottom line for patients and referring clinicians: Mass General’s sharp ranking rise signals genuine clinical improvement, not repositioning — and its trial portfolio and research depth make it a strong option for patients who prioritize access to emerging therapies in the Northeast.

What This Means for Healthcare Professionals

The 2025–2026 rankings surface a pattern that extends beyond individual hospital performance: institutions with the strongest team communication infrastructure, multidisciplinary tumor boards, coordinated handoff protocols, and integrated care teams, consistently outperform on the outcome metrics that drive these rankings.

Massachusetts General’s rise from No. 11 to No. 5 is the clearest data point. The “For Every Patient” strategy that drove the jump was fundamentally a communication and care coordination initiative. Reduced inpatient mortality followed.

For hospital administrators and clinical leaders, this validates a direct investment thesis: structured clinical communication — whether through dedicated oncology team huddles, secure messaging platforms like HosTalky, or integrated EHR-based coordination tools — is not ancillary to care quality. It is a documented driver of the outcomes that regulators, payers, and rankings now measure.

FAQs

Conclusion

The fight against cancer is ongoing, but the United States stands at the forefront of innovative treatments and exceptional care.  These top cancer hospitals offer a beacon of hope for patients, providing access to leading specialists, cutting-edge technologies, and groundbreaking therapies.  

Whether you’re seeking a specific treatment or a comprehensive approach, these institutions are equipped to deliver the best possible outcomes. Remember, this list is not exhaustive, and the ideal hospital depends on your individual needs.  

Don’t hesitate to consult with your doctor to determine the best course of action for your unique situation.  With continued research and dedication, the future of cancer care looks brighter than ever.